HAUMANN BRETT K 4
4 · Theravance Biopharma, Inc. · Filed May 22, 2019
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2019-05-20$19.84/sh−2,705$53,667→ 236,678 total
4 · Theravance Biopharma, Inc. · Filed May 22, 2019
Ordinary Shares